Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IMO Schwartz stock sales may be the key that unravels this conundrum
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Are you saying there could be a redistribution of revenue from PDS with regard to the J's settlement???...say TPL got 75% and PTSC got 25% of J's settlement (hypothetical) to actually 'hide' the numbers since TPL doesn't have to report earnings.

Maybe I misunderstood your statement but I don't believe this scenario can legally occur since PTSC's percentage of license revenue receipts are to be 50% of PDS.

Regards,
PxP

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply